Form D · Biotechnology
ThirdLaw Molecular, Inc.
Blue Bell, PA · CIK 0002086735
Offering snapshot reported Oct 8, 2025 · SEC filing
- Reported sold
- $5.5M Offering amount: $5.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 2, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2025 | Initial | $5,500,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-560187
The Total Offering Amount and Total Amount Sold includes the conversion of outstanding convertible securities.
Source: Form D, filed Oct 8, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Halak | Director |
| Eric Heil | Director, Executive |
| Christian Schafmeister | Director, Executive |
| David Scheer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
512 East Township Line Road 4 Valley Square
Blue Bell, PA, 19422
Blue Bell, PA, 19422